Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)
Direct Payment
$105,000.00
Detection, molecular basis and clinical significance of antibiotic tolerance in Staphylococcus aureus
FY 2022-23
Summary
Bacterial infections are a major global cause of mortality, and antibiotics are critical to their treatment. However, our ability to cure these infections is being threatened by the rise of antibiotic resistance and even common bacterial infections are becoming increasingly difficult to treat. Given the lack of new antibiotics being discovered, it is important that we preserve the effectiveness of existing antibiotics to combat infections. In addition to the ever-growing problem of resistance, antibiotic tolerance is an emerging bacterial phenomenon that poses a challenge to antibiotic treatment. Tolerant bacteria are still killed by antibiotics, but at a slower rate. The slower rate of killing means that tolerant bacteria can survive the typical course of antibiotic treatment, resulting in persistent and recurrent infections. Unlike antibiotic resistance, which is identified by routine testing in laboratories, tolerance is not detected because there are currently no tests available to do so. Consequently, the clinical prevalence and significance of tolerance is unknown. I have developed a simple tolerance screen that I will apply to libraries of clinical isolates from patients with persistent infections to determine the prevalence of tolerance. I will also investigate the molecular mechanisms behind tolerance in these clinical isolates and evaluate the effect of tolerance on antibiotic treatment outcomes in infection models. Ultimately, this research will improve the diagnosis and treatment of persistent infections by providing physicians with a tool to detect tolerance and scientists with a better understanding of the mechanisms behind it. The findings from this project will allow better use of existing antibiotics, and potentially lead to the development of anti-tolerance therapeutics. Overall, addressing the threat of antibiotic tolerance will help ensure that we can provide effective antibiotic therapy and treat bacterial infections in the future.
Department
Program
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Recipient
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
474144
Name
Deventer Ashley
Country
United Kingdom
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Detection, molecular basis and clinical significance of antibiotic tolerance in Staphylococcus aureus
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Antibiotic Resistance; Antibiotic Tolerance; Bacteremia; Clinical Isolates; Minimum Duration Of Killing; Mutation; Persistent Infections; Staphylococcus Aureus; Stringent Response; Time-Kill Assay
Abstract
Bacterial infections are a major global cause of mortality, and antibiotics are critical to their treatment. However, our ability to cure these infections is being threatened by the rise of antibiotic resistance and even common bacterial infections are becoming increasingly difficult to treat. Given the lack of new antibiotics being discovered, it is important that we preserve the effectiveness of existing antibiotics to combat infections. In addition to the ever-growing problem of resistance, antibiotic tolerance is an emerging bacterial phenomenon that poses a challenge to antibiotic treatment. Tolerant bacteria are still killed by antibiotics, but at a slower rate. The slower rate of killing means that tolerant bacteria can survive the typical course of antibiotic treatment, resulting in persistent and recurrent infections. Unlike antibiotic resistance, which is identified by routine testing in laboratories, tolerance is not detected because there are currently no tests available to do so. Consequently, the clinical prevalence and significance of tolerance is unknown. I have developed a simple tolerance screen that I will apply to libraries of clinical isolates from patients with persistent infections to determine the prevalence of tolerance. I will also investigate the molecular mechanisms behind tolerance in these clinical isolates and evaluate the effect of tolerance on antibiotic treatment outcomes in infection models. Ultimately, this research will improve the diagnosis and treatment of persistent infections by providing physicians with a tool to detect tolerance and scientists with a better understanding of the mechanisms behind it. The findings from this project will allow better use of existing antibiotics, and potentially lead to the development of anti-tolerance therapeutics. Overall, addressing the threat of antibiotic tolerance will help ensure that we can provide effective antibiotic therapy and treat bacterial infections in the future.
Competitiondate
202210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Deventer, Ashley
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~